Phase 4 N=135 A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients
Diabetes Mellitus, Type 2
Primary: Percentage of Participants Achieving Hemoglobin A1c (HbA1c) Below 6.5% at Week 48 Endpoint — 18.5 percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=100 Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients.
Chronic Heart Failure
Primary: Change From Baseline in Echocardiographic Left Ventricular Ejection Fraction (LVEF) According to the Genetic Polymorphism of Beta-1 Adrenergic Receptor-CG at Week 26 or…
Phase 4 N=20 Temperature Control in Central Fever in the Neuro-ICU
Fever · Brain Hemorrhage
Primary: Core Temperature as Measured With an Approved Device (Urinary Catheter) in Place for Usual Clinical Care — 100.8; 100.3; 99.9; 99.5 degrees F
Phase 4 N=60 Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
Moderate to Severe Psoriasis
Primary: Percentage of Participants Achieving a 75 Percent (%) Improvement in Psoriasis Area and Severity Index (PASI 75) Score at Week 24 — 52.38; 57.89; 22.22 percentage of…
Phase 4 N=30 Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
Bipolar Disorder · Mania
Primary: Change in Bipolar Symptoms as Measured by Reduction in Young-Mania Rating Scale (Y-MRS) Total Score — -14.5 Units on a scale
Phase 4 N=114 Arthralgia During Anastrozole Therapy for Breast Cancer
Early Breast Cancer
Primary: Number of Participants With New Events of Arthralgia — 37 Participants
Phase 4 N=51 Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
Bipolar Disorder · Mania
Primary: Change of Mania Symptoms Assessed by Young Mania Rating Scale (YMRS) — -14.9 Units on a scale
Phase 4 N=21 Effect of Pulse Width With Spinal Cord Stimulation
Pain · Chronic Pain · Back Pain
Primary: Pain Severity, as Measured on the 11-point (0-10) Numerical Rating Scale (NRS) — -56.1 Percent Change in Pain Rating
Phase 4 N=96 Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder
Primary: Attention Deficit / Hyperactivity Disorder Total Sum Score of All 18 ADHD Symptom Items — 26.54; 25; 18.94; 18.46 Score
Phase 4 N=20 Optimized Programming in Spinal Cord Stimulation (SCS) System
Neuropathic Pain · Pain
Primary: Correlation Coefficient Between Dorsal Root Paresthesia (Total Pixels Derived From Digital Drawing) at Maximum-comfortable Stimulation Level and Anode-cathode Separation…
Phase 4 N=506 Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
Essential Hypertension
Primary: Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) — -18.80; -20.78 mmHg
Phase 4 N=49 Compare Anti-inflammatory Dentifrices
Gingivitis
Primary: Gingival Index (GI) — 1.04; 1.01 units on a scale — p=<0.05
Phase 4 N=53 Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
Acne Vulgaris
Primary: Skin Erythema (Redness) — 1.06; 1.18; 1.26; 1.34 Units on a scale — p=> 0.05
Phase 4 N=215 Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
Allergic Conjunctivitis
Primary: Overall Patient Satisfaction — 70.1 Percentage of Participants
Phase 4 N=315 Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
Hypertension · Left Ventricular Hypertrophy
Primary: Percent Change of B Type Natriuretic Peptides (BNP) Level — -29.2 Percent Change